The Effectiveness of Tailored Messages on the Usage of Emollient in Patients With Atopic Dermatitis

Dermatitis, Atopic Clinical Trial

Official title:

The Effectiveness of Tailored Messages on the Usage of Emollient in Patients With Atopic Dermatitis: A Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02343861
• Other study ID #: 16-2014-154
• Status: Completed
• Phase: N/A
• First received: January 16, 2015
• Last updated: March 14, 2018
• Start date: January 2015
• Est. completion date: May 2015

Study information

• Verified date: March 2018
• Source: Seoul National University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Atopic dermatitis is the most common chronic inflammatory skin disease in children and severely affects quality of life (QoL) of patients and their parents. The application of topical medications and emollient is the mainstay of the treatment, but complexity of the treatment and lack of self-care knowledge cause poor adherence, leading to therapeutic failure. Adequate education about the chronic disease and its treatment was known to improve the treatment adherence. There are a variety forms like generalized information leaflets and video clips for imparting information to patients and individualized tailoring education was considered more effective way to improve patients' adherence. The aim of this study is to determine the efficacy of tailored education in dermatology area, especially the emollient usage in patients with atopic dermatitis.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 24
• Est. completion date: May 2015
• Est. primary completion date: May 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 20 Years and older

Eligibility

Inclusion Criteria:

• A parent of 0-5 year old children with mild to moderate atopic dermatitis

• 20 years of age or older

• Apply emollient for themselves to their children with atopic dermatitis

Exclusion Criteria:

• Parents of children with severe atopic dermatitis or showing signs of acute infection (Oozing, vesicles, edema, redness or pain)

Related Conditions & MeSH terms

• Dermatitis
• Dermatitis, Atopic
• Eczema

Intervention

Behavioral:
• Tailored leaflet group
Parents in intervention group will receive an patient education leaflet and watch an educational video about lifestyle recommendations, and the use of emollients. In addition to general information, parents in intervention group will also receive the tailored leaflet including the estimated amount of emollients based on the body surface area.
• Control group
Participants (parents of children with atopic dermatitis) in control group will receive an patient education leaflet and watch an educational video about lifestyle recommendations, and the use of emollients.

Locations

Country	Name	City	State
Korea, Republic of	Department of Dermatology, Seoul National University Boramae Hospital	Seoul

Sponsors (1)

Lead Sponsor	Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

References & Publications (1)

Park GY, Park HS, Cho S, Yoon HS. The Effectiveness of Tailored Education on the Usage of Moisturizers in Atopic Dermatitis: A Pilot Study. Ann Dermatol. 2017 Jun;29(3):360-362. doi: 10.5021/ad.2017.29.3.360. Epub 2017 May 11. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change of the weekly amount of emollient used	Parents of patients are asked to bring the emollients to each visit at which time the emollients are weighed.	Two weeks
Secondary	Average daily number of emollient usage		Two weeks
Secondary	Average daily number of topical medication (other than emollient) usage		Two weeks
Secondary	Investigator's Global Assessment (IGA)	At each visit, disease severity will be assessed using the Investigator's Global Assessment (IGA).	Two weeks
Secondary	Eczema Area and Severity Index (EASI)	At each visit, disease severity will be assessed using the Eczema Area and Severity Index (EASI).	Two weeks